Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam CYP3A4 phenotyping in prostate cancer versus other solid tumors
NL-OMON51249Completed
- Sponsor
- Netherlands Cancer Institute
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of midazolam (2 arms), sponsored by Netherlands Cancer Institute. Started Apr 2021; status: completed.
02
Drugs
midazolam
Beyond the preview
Go deeper on NL-OMON51249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51249.